FDA deactivated import alert on genetically engineered salmon

The FDA announced that it is committed to helping food developers bring biotechnology innovations to market while at the same time providing consumers with high safety standards. In 2015 FDA approved an AquAdvantage Salmon, a Genetically Engineered (GE) Atlantic salmon that contains the first approved intentional genomic alterations (IGAs) in an animal intended for food use. Today, the FDA is deactivating a 2016 import alert that prevented GE salmon from entering the U.S. However, product alerts were required by Congress. The FDA’s approval of the application related to AquAdvantage Salmon followed a comprehensive analysis of the scientific evidence, which determined that the GE Atlantic salmon met the statutory requirements for safety and effectiveness under the Federal Food, Drug, and Cosmetic Act. The FDA no longer has the authority to issue labeling guidance on this topic; however, the FDA believes this Congressional mandate has been satisfied by the USDA’s issuance of final regulations implementing that law in late 2018 because the law contains labeling indicating that it is bioengineered. @ https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632952.htm?utm_campaign=3-8-2019-GESalmon&utm_medium=email&utm_source=Eloqua" rel="nofollow noopener noreferrer" target="_blank">https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm632952.htm?utm_campaign=3-8-2019-GESalmon&utm_medium=email&utm_source=Eloqua
Statement from FDA Commissioner Scott Gottlieb, M.D., on continued efforts to advance safe biotechnology innovations, and the deactivation of an import alert on genetically engineered salmon

Statement from FDA Commissioner Scott Gottlieb, M.D., on continued efforts to advance safe biotechnology innovations, and the deactivation of an import alert on genetically engineered salmon

No comments

Leave a Reply